One-on-One with the National Alliance of Healthcare Purchaser Coalitions
National Alliance of Healthcare Purchaser Coalitions interviews CLS’ Scott Megill
National Alliance of Healthcare Purchaser Coalitions interviews CLS’ Scott Megill
Coriell Life Sciences’ Scott Megill examines the value of scalable precision prescribing and the benefits of pharmacogenomics.
CLS relies on precision medicine to improve medication impact, reduce adverse drug events, and tailor treatment based on DNA.
CLS makes better use of the information and tools we already have to lessen the impact of COVID-19 outbreaks.
Featuring Quest Diagnostics, TRS, and CLS.
Corigen® resulted in medication improvements for 64% of the pension plan’s population.